Tower Research Capital (TRC)’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,592
| Closed | -$82.2K | – | 5263 |
|
|
2025
Q3 | $82.2K | Sell |
5,592
-8,474
| -60% | -$86.4K | ﹤0.01% | 2156 |
|
|
2025
Q2 | $138K | Buy |
14,066
+10,859
| +339% | +$89.9K | ﹤0.01% | 2111 |
|
|
2025
Q1 | $23.3K | Sell |
3,207
-8,518
| -73% | -$74.5K | ﹤0.01% | 2821 |
|
|
2024
Q4 | $91.7K | Buy |
11,725
+6,132
| +110% | +$50.5K | ﹤0.01% | 2186 |
|
|
2024
Q3 | $41.4K | Sell |
5,593
-17,633
| -76% | -$148K | ﹤0.01% | 2827 |
|
|
2024
Q2 | $186K | Buy |
23,226
+22,065
| +1,901% | +$197K | ﹤0.01% | 2134 |
|
|
2024
Q1 | $13.5K | Sell |
1,161
-3,639
| -76% | -$40.3K | ﹤0.01% | 3386 |
|
|
2023
Q4 | $53.6K | Sell |
4,800
-5,241
| -52% | -$48.2K | ﹤0.01% | 3090 |
|
|
2023
Q3 | $155K | Buy |
10,041
+8,165
| +435% | +$137K | ﹤0.01% | 1631 |
|
|
2023
Q2 | $35.6K | Sell |
1,876
-6,303
| -77% | -$111K | ﹤0.01% | 2875 |
|
|
2023
Q1 | $125K | Buy |
8,179
+5,120
| +167% | +$66.8K | ﹤0.01% | 1666 |
|
|
2022
Q4 | $39K | Sell |
3,059
-8,393
| -73% | -$75.5K | ﹤0.01% | 2526 |
|
|
2022
Q3 | $67K | Buy |
11,452
+9,139
| +395% | +$40.2K | ﹤0.01% | 2896 |
|
|
2022
Q2 | $7K | Sell |
2,313
-1,434
| -38% | -$4.33K | ﹤0.01% | 4785 |
|
|
2022
Q1 | $14K | Buy |
3,747
+927
| +33% | +$5.97K | ﹤0.01% | 3882 |
|
|
2021
Q4 | $37K | Buy |
2,820
+2,404
| +578% | +$38K | ﹤0.01% | 3020 |
|
|
2021
Q3 | $8K | Sell |
416
-7,776
| -95% | -$142K | ﹤0.01% | 4532 |
|
|
2021
Q2 | $153K | Buy |
8,192
+6,615
| +419% | +$148K | ﹤0.01% | 2117 |
|
|
2021
Q1 | $37K | Buy |
1,577
+278
| +21% | +$6.42K | ﹤0.01% | 3372 |
|
|
2020
Q4 | $32K | Sell |
1,299
-2,456
| -65% | -$62.8K | ﹤0.01% | 3511 |
|
|
2020
Q3 | $96K | Buy |
3,755
+993
| +36% | +$31.5K | ﹤0.01% | 3172 |
|
|
2020
Q2 | $55K | Buy |
+2,762
| New | +$67.1K | ﹤0.01% | 2969 |
|
Other funds holding ETNB
Tower Research Capital (TRC)'s ETNB Position: Q4 2025 in Review
Tower Research Capital (TRC) sold out of 89bio (ETNB) in Q4 2025, closing a stake of 5,592 shares — an estimated $82.2K sold.
Tower Research Capital (TRC) first reported a position in ETNB in Q2 2020 and held it in 22 quarters. The position peaked at $186K in Q2 2024. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Tower Research Capital (TRC) reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 5,592 89bio shares in Q4 2025, an estimated $82.2K.
- Tower Research Capital (TRC) first reported a position in 89bio in Q2 2020 and held it in 22 quarters.
- Tower Research Capital (TRC)'s 89bio position peaked at $186K in Q2 2024.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.